Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized for You
we will pick new questions that match your level based on your Timer History
Track Your Progress
every week, we’ll send you an estimated GMAT score based on your performance
Practice Pays
we will pick new questions that match your level based on your Timer History
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Thank you for using the timer!
We noticed you are actually not timing your practice. Click the START button first next time you use the timer.
There are many benefits to timing your practice, including:
GMAT Inequalities is a high-frequency topic in GMAT Quant, but many students struggle because the concepts behave differently from standard algebra. Understanding the right rules, patterns, and edge cases can significantly improve both speed and accuracy.
In Episode 3 of our GMAT Ninja Critical Reasoning series, we tackle Discrepancy, Paradox, and Explain an Oddity questions. You know the feeling: the passage gives you two facts that seem completely contradictory....
Join the special YouTube live-stream for selecting the winners of GMAT Club MBA Scholarships sponsored by Juno live. Watch who gets these coveted MBA scholarships offered by GMAT Club and Juno.
From the mid-1980s through the early-2000s, specialty substance abuse centers, facilities that provide both residential and outpatient treatment services, emerged as dominant players in national substance abuse treatment. During the early to mid-1990s, expensive inpatient and residential treatment, viewed as less cost effective than intensive outpatient treatment models, were targeted as an area for cost-cutting, particularly for private insurance.
Concurrently, and throughout this time period, sales of prescription drugs have remained a minor portion of spending for substance abuse treatment. Only a few drugs are available to treat substance disorders. In 2004, acamprosate joined two, other previously FDA approved medications–disulfiram and naltrexone–for the treatment of alcoholism. Buprenorphine for the for the treatment of opiate addiction was approved in 2002. Methadone for treatment of opioid addiction is not available as a retail prescription drug and spending for methadone is included with specialty substance abuse centers.
The substance abuse public payer mix is expected to shift toward programs that are wholly or partially funded by state and local governments.
Other state and local spending is expected to continue to increase as a share of substance abuse spending throughout the projection period, rising from a 29 percent share in 1986 and a 40 percent share in 2003 to a projected 42 percent share in 2006 and 45 percent share in 2014 as reflected in the figure below.
For each of the following, select \(Yes\) if it is a likely treatment area for specialty substance abuse treatment centers as indicated in the tabs. Otherwise, select \(No\).??????
For each of the following, select \(Yes\) if it is a likely treatment area for specialty substance abuse treatment centers as indicated in the tabs. Otherwise, select \(No\).??????
Yes
No
Alcohol-induced or drug-induced psychoses
Methadone administration
Pervasive development disorders
Show more
Both of these disorders are categorized as substance abuse according to tab 3.
Correct answer: Alcohol-induced or drug-induced psychoses: Yes Methadone administration: Yes Pervasive development disorders: No